Description: This 1980 session covers amendments to the SNL and SVL and the anticipated revision to the CSO Mortality Table. Questions discussed: 1. What changes can be expected in requirements in the1980's? 2. What changes in products design will likely emerge from these? 3. What will be the effect on future gross premium, cash value, and reserve levels? 4. Will these changes be compatible with all economic forecast scenarios? 5. Will these changes create a need for increased gross premium rates or for higher company surplus levels? 6. Should attention to solvency measures be increased? 7. Are the allowable valuation interest rates sufficiently liberal?

Description: The purpose of this survey is to gather a high-level view of U.S. Group Term Life Insurance mortality results during the COVID-19 pandemic, as compared to prior period baseline mortality results. The datasets for this report encompass all Group Term Life claims reported to participating carriers as of August 31, 2020. The Committee is grateful that 20 of the top 21 U.S. Group Term Life insurers are participating in this survey, with market share representing roughly 90% of the industry.

Description: Discuss changes in group life waiver of premium claim recovery and mortality experience since the 2005 table was released, the development of the 2023 table, and the new statutory valuation standard approved by the National Association of Insurance Commissioners (NAIC).

Description: In this article, the author presents a study on Egyptian life insurance mortality for ordinary standard life insurance business in Egypt, for the period July 7, 2003 to June 30, 2006.

Description: This report summarizes the results of a 2022 survey examining mortality improvement practices of life and annuity companies in the U.S. and Canada.

Description: One of the evolving datasets with the COVID-19 Research Database is the Datavant population mortality information. This report notes the features of the database, discuss their potential use and limitations, examines data reliability and reviews it potential use as an additional data set and input to mortality improvement models.

Description: The Society of Actuaries (SOA) has partnered with LIMRA and the American Council of Life Insurance (ACLI) to conduct a series of ‘sprint’ surveys on the coronavirus (COVID-19) pandemic and its potential impacts on the U.S. life insurance industry. This report contains a summary of the results of the second survey on best practices in monitoring and modeling the potential impact of COVID-19 mortality on life insurance industry claims.

Description: Using recently updated data from the United States Mortality Database (USMDB, usa.mortality.org), this report presents an overview of historical mortality trends in all 50 U.S. states and the District of Columbia for the period 1959-2018.

Description: Mortality is a fundamental element in the financial projections of the finances of social security programs around the world. Prominent actuaries from the U.S. Social Security Administration, Canada's Office of Superintendent of Financial Institutions and the U.K. Government Actuary's Department will discuss some of the key factors and current issues associated with these projections. Improving mortality has and will have a significant effect on the affordability and importance of income through retirement to many population segments in these countries.

Description: The Group Life COVID-19 Mortality Survey gathers a high-level view of U.S. Group Term Life Insurance mortality results during the COVID-19 pandemic through June 2023, as compared to prior period baseline mortality results. This new report is an update to the survey report released in May 2023, which contained data through December 2022.